Regeneron Pharmaceuticals Inc (REGN)
Interest coverage
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 5,187,200 | 4,911,400 | 5,032,000 | 4,835,100 | 5,032,400 | 4,654,200 | 4,113,100 | 4,272,300 | 4,448,500 | 4,845,000 | 4,719,500 | 4,918,200 | 6,093,600 | 6,399,300 | 9,190,200 | 9,383,100 | 8,105,000 | 7,298,800 | 4,460,200 | 3,867,300 |
| Interest expense (ttm) | US$ in thousands | 42,100 | 36,600 | 47,800 | 55,200 | 63,000 | 67,000 | 71,100 | 73,000 | 72,100 | 69,600 | 63,800 | 59,400 | 56,100 | 55,000 | 56,300 | 57,300 | 58,000 | 70,100 | 65,400 | 56,900 |
| Interest coverage | 123.21 | 134.19 | 105.27 | 87.59 | 79.88 | 69.47 | 57.85 | 58.52 | 61.70 | 69.61 | 73.97 | 82.80 | 108.62 | 116.35 | 163.24 | 163.75 | 139.74 | 104.12 | 68.20 | 67.97 |
September 30, 2025 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $5,187,200K ÷ $42,100K
= 123.21
Peer comparison
Sep 30, 2025
Company name
Symbol
Interest coverage
Regeneron Pharmaceuticals Inc
REGN
123.21
Arrowhead Pharmaceuticals Inc
ARWR
0.93
Biomarin Pharmaceutical Inc
BMRN
64.46
See also:
Regeneron Pharmaceuticals Inc Interest Coverage (Quarterly Data)